Thursday, March 17, 2005
Columnist says Feds are Ready to Charge Caremark Rx with Medicaid Fraud
Two Justice Department officials told a judge last month that they plan to seek control of a multistate Medicaid investigation against Caremark Rx that has been kept secret for some time, according to a columnist from TheStreet.com. Columinst Melissa Davis writes that the case is based on a pending whistleblower lawsuit and could ultimately decide whether Caremark—or perhaps even the company’s unsuspecting customers—owes Medicaid significant sums of money.
To read the entire column at TheStreet.com, click here.
Posted by Quitam Help Admin on 03/17 at 02:55 PM
Wednesday, March 16, 2005
Massachusetts Investigating "Big Dig" Contractors
The Massachusetts attorney general is investigating two of the largest contractors in the $14.6 billion Big Dig highway project amid new questions about the project’s safety, according to a story from the Associated Press in Boston today.
The civil investigation into Bechtel/Parsons Brinckerhoff and Modern Continental Construction Co. focuses on what Attorney General Thomas Reilly called poor oversight and shoddy work on the project, a system of bridges and tunnels plagued by cost overruns and riddled by leaks and other flaws. The outside engineer who led an investigation into leaks at the project said in a March 9 letter to the Massachusetts Turnpike Authority that he can no longer vouch for the safety of its tunnels. Read the entire story here.
Posted by Quitam Help Admin on 03/16 at 09:36 AM
Tuesday, March 08, 2005
Fraud Involving Defective Rats Leads to $7.2 Million False Claims Act Settlement
A major supplier of laboratory mice and rats agreed to pay $7.2 million in damages after it was charged with providing a government agency with defective rodents and then failing to disclose the problem.
The company, Harlan, Sprague, Dawley, Inc. of Indianapolis, had provided laboratory rodents for federally funded research on aging since 1997. According to an account of the settlement in the Baltimore Sun, Harlan discovered potential genetic flaws in the animals in 1999 but failed to report the defect to the client agency. Harlan agreed to pay the government $7.2 million to settle claims under the False Claims Act, but admitted no wrongdoing. Read the details here.
Posted by Quitam Help Admin on 03/08 at 02:23 PM
Monday, March 07, 2005
Texas Leads Charge Against Pharmas that Defraud
A feature article in The Texas Observer chronicles the Lone Star State’s leadership role in seeking damages from large pharamceutical companies for Medicaid fraud. Since September 2000, when Texas became the first state to intervene in whistleblower-initiated litigation focused on drug pricing fraud, the state has received a total of $45.5 million in settlements. And now other states are following suit. Read the complete account here.
Posted by Quitam Help Admin on 03/07 at 12:40 PM
Friday, March 04, 2005
Northrop Grumman agrees to $62 million Settlement of Qui Tam Case
Northrop Grumman Corporation has agreed to settle a 16-year-old complaint filed by four employees of Northrop Corporation and the U.S. Department of Justice under the qui tam provisions of the civil False Claims Act (U.S. ex rel. Rex Robinson v. Northrop Grumman Corporation).
The company said it will pay approximately $62 million to settle all claims, including that Northrop in the 1980s inappropriately accounted for scrap parts at its facility in Rolling Meadows, Ill. The company also has agreed to settle the relators’ personal claims, including their claim for attorney fees, and to reimburse the government for previously billed legal costs incurred by the company.
Northrop Grumman Corporation is a global defense company headquartered in Los Angeles. The company has more than 125,000 employees and operates in all 50 states and 25 countries and serves U.S. and international military, government and commercial customers.
Posted by Quitam Help Admin on 03/04 at 12:25 PM
Page 2 of 3 pages < 1 2 3 >
Printer Friendly Page